✦ LIBER ✦

Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin lymphoma

✍ Scribed by Lim, SeahH.; Davey, Gilllian; Marcus, Robert

Book ID: 122608270
Publisher: The Lancet
Year: 1993
Tongue: English
Weight: 336 KB
Volume: 341
Category: Article
ISSN: 0140-6736
DOI: 10.1016/0140-6736(93)93024-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

REMISSION INDUCTION IN NON-HODGKIN LYMPH

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

✍ HALE, G 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 1020 KB

Monoclonal antibody therapy with CAMPATH

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

✍ M. Uppenkamp; A. Engert; V. Diehl; D. Bunjes; D. Huhn; G. Brittinger 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 55 KB

Use of Ibritumomab Tiuxetan Anti-CD20 Ra

Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin's Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody

✍ Tsai, Donald E.; Maillard, Ivan; Schuster, Stephen J.; Nasta, Sunita D.; Porter, 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 478 KB

A Dose-Escalation Study of SAR3419, an A

A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

✍ Ribrag, V.; Dupuis, J.; Tilly, H.; Morschhauser, F.; Laine, F.; Houot, R.; Haiou 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 295 KB